A new study shows Fosamax is effective in treating osteoporosis, but may not work the way experts believed.
-
31Dec
Tags: Drug
-
31Dec
A team of scientists from the US and China have discovered that grape-seed extract kills laboratory leukemia cells by making them commit suicide, thus showing the potential value of natural compounds in the treatment of cancer.
-
31Dec
A new study shows that medication errors are common among children and adults taking chemotherapy drugs at home or in outpatient clinics.
-
31Dec
Grape seed extract may have potential in curbing leukemia, new research shows.
-
31Dec
Ophthalmologist Andrew Iwach shares tips on the safe way to open champagne bottles and avoiding eye damage from flying corks.
Tags: Health
-
31Dec
Eclipsys Corp., an Atlanta-based health care software company, plans to purchase Premise Corp., which sells patient flow software. Eclipsys announced Dec. 30 that it will pay $38.5 million in cash in a deal expected to close within 15 days.
Tags: Health, Health Care
-
31Dec
Two technology vendors and a group practice have met the new CORE standard for electronic administrative data communications. They are: MD On-Line Inc., RealMed Corp. and Summit Medical Group.
Tags: Health
-
31Dec
Source: Food and Drug Administration
Tags: Drug, Food and Drug Administration, Health, HIV
-
31Dec
C, E and beta carotene didn’t halt women’s risk of developing disease.
Source: HealthDay -
31Dec
Yet simple lifestyle changes can make all the difference.
Source: HealthDay -
31Dec
Those with variant had cancer as well as idiopathic pulmonary fibrosis, study finds.
Source: HealthDay -
31Dec
US researchers studying the effect of beta carotene, vitamin C and vitamin E, either singly or in combination, on over 7,000 women found the supplements did not reduce their risk of getting cancer compared to women who did not take the supplements.
-
31Dec
EPA has notified 25 governors and 23 tribal leaders that certain areas in their states and tribal lands do not meet the agency’s daily standards for fine particle pollution, also known as PM 2.5. “These designations are an important step in our steady march toward cleaner air,” said EPA Administrator Stephen L. Johnson.
-
31Dec
A second cholera outbreak has hit Chegutu, a town 100 km west of Harare, where more than 100 people have died since the first cases appeared on November 24. MSF arrived in Chegutu, which has a population of 55,000, on December 12 after being told that day of the cholera emergency there. The scene MSF found at the town’s small government cholera treatment center (CTC) was grim.
-
31Dec
Massive forced civilian displacements, violence, and unmet medical needs in the Democratic Republic of Congo, Somalia, Iraq, Sudan, and Pakistan, along with neglected medical emergencies in Myanmar and Zimbabwe, are some of the worst humanitarian and medical emergencies in the world, the internationa
Tags: Doctor
-
31Dec
The Ministry of Health (MoH) of the Democratic Republic of the Congo declared on 25 December an outbreak of Ebola haemorrhagic fever in Mweka District, Kasai Occidental province based on laboratory results from the Centre International de Recherches Médicales de Franceville (CIRMF) in Gabon.
Tags: Health
-
31Dec
The U.S. Food and Drug Administration is alerting consumers nationwide not to purchase or consume more than 25 different products marketed for weight loss because they contain undeclared, active pharmaceutical ingredients that may put consumers’ health at risk.
Tags: Drug, Food and Drug Administration, Health, U.S.
-
31Dec
The U.S. Food and Drug Administration today approved Vasovist Injection (gadofosveset trisodium), the first contrast imaging agent for use in patients undergoing magnetic resonance angiography, or MRA, a minimally invasive test for examining blood vessels.
Tags: Drug, Food and Drug Administration, U.S.
-
31Dec
Dynavax Technologies Corporation (Nasdaq:DVAX) today announced the termination of a global license and development collaboration agreement with Merck & Co., Inc. for HEPLISAVTM, a Phase 3 hepatitis B virus (HBV) vaccine. All rights to develop and commercialize HEPLISAV revert to Dynavax.
Tags: Virus
-
31Dec
First Patient Enrolled In Open-Label, Switchover Trial Of PrGCD For The Treatment Of Gaucher Disease
Protalix BioTherapeutics, Inc. (Amex: PLX), announced today enrollment of the first patient in a worldwide, multi-center, open-label, switchover trial to assess the safety and efficacy of prGCD.
Tags: Treatment
Recent Comments